Literature DB >> 7263814

Convenient and sensitive high-performance liquid chromatography assay for cimetidine in plasma or urine.

M G Kunitani, D A Johnson, R A Upton, S Riegelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263814     DOI: 10.1016/s0378-4347(00)80151-6

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  A high-performance liquid chromatographic microassay employing a liquid-solid extraction technique for etintidine in plasma.

Authors:  S M Huang; E Rubin; T B Marriott
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.

Authors:  Ekarat Jantratid; Sompol Prakongpan; Gordon L Amidon; Jennifer B Dressman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

5.  Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.

Authors:  R H Barbhaiya; U A Shukla; D S Greene
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

Review 6.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.